secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001193125-23-014676
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q4 GAAP EPS $3.93, adj. $5.23; revenue up 10.1% to $39.7B; FY revenue $155.7B; dividend raised 16%
--------------------------------------------------------------------------------

- GAAP EPS Q4 $3.93, FY $24.81; adjusted EPS Q4 $5.23, FY $29.07.
- Full-year operating revenue $155.7B (+13.7% YoY); operating gain $8.5B (+12.9%).
- Medical membership 47.5M (+2.2M YoY); growth in Medicaid, commercial fee-based.
- Quarterly dividend raised 16% to $1.48; new annualized rate $5.92 per share.
- Board authorized $5.0B increase to share repurchase program; 2023 guidance: GAAP EPS >$29.80, adjusted >$32.60.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/d418386d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-014676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer